hsTnT in Patients Admitted to the ED With Atrial Fibrillation in the Era of NOACs - Heidelberg Registry of Atrial Fibrillation

• Conditions: Atrial Fibrillation

• Registration Number: NCT03344237
• Lead Sponsor: University Hospital Heidelberg

Brief Summary

The purpose of the Heidelberg Registry of Atrial Fibrillation (HERA-FIB) is to collect data on the prevalence and clinical significance of elevated cardiac troponin in a large registry of unselected patients with atrial fibrillation presenting to an emergency department in the era of novel oral anticoagulants (NOACs).

Detailed Description

Not available

Study Timeline

• Study Start: 2017-09-14
• Study First Submitted: 2017-11-11
• Study First Submitted QC: 2017-11-11
• Study First Posted: 2017-11-17
• Status Verified: 2019-09
• Last Update Submitted: 2019-09-26
• Last Update Posted: 2019-09-27
• Primary Completion: 2019-11-01
• Study Completion: 2020-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

• documented atrial fibrillation
• availability of at least one hsTnT measurement

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vascular and non-vascular death	Follow up after at least 6 months
Stroke/systemic embolism	Follow up after at least 6 months
Nonfatal myocardial infarction	Follow up after at least 6 months

Secondary Outcome Measures

Name	Time	Method
Stroke, systemic embolism, myocardial infarction, vascular death, non-vascular death, composite endpoint of vascular and non-vascular death, nonfatal MI, stroke/systemic embolism	Follow up after at least 6 months

Trial Locations

Locations (1)

Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital; 🇩🇪 Heidelberg, Baden-Württemberg, Germany